BCWORLD PHARM. Co. Ltd Asset Resilience Ratio

Latest as of September 2025: 2.37%

BCWORLD PHARM. Co. Ltd asset resilience ratio. BCWORLD PHARM. Co. Ltd (200780) has an Asset Resilience Ratio of 2.37% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 200780 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩4.13 Billion
≈ $2.80 Million USD Cash + Short-term Investments

Total Assets

₩173.79 Billion
≈ $117.78 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of BCWORLD PHARM. Co. Ltd (2016–2024)

Asset resilience ratio of BCWORLD PHARM. Co. Ltd from 2016 to 2024. This chart shows how BCWORLD PHARM. Co. Ltd's Asset Resilience Ratio has changed over time. Read BCWORLD PHARM. Co. Ltd (200780) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down BCWORLD PHARM. Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of BCWORLD PHARM. Co. Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents ₩0.00 0%
Short-term Investments ₩4.13 Billion 2.37%
Total Liquid Assets ₩4.13 Billion 2.37%

Asset Resilience Insights

  • Limited Liquidity: BCWORLD PHARM. Co. Ltd maintains only 2.37% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

BCWORLD PHARM. Co. Ltd Industry Peers by Asset Resilience Ratio

Compare BCWORLD PHARM. Co. Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Merck & Company Inc
NYSE:MRK
Drug Manufacturers - General 0.22%
AstraZeneca PLC
NASDAQ:AZN
Drug Manufacturers - General 0.10%
Pfizer Inc
SA:PFIZ34
Drug Manufacturers - General 5.33%
Novartis AG
MX:NVSN
Drug Manufacturers - General 0.08%
Pfizer Inc
NYSE:PFE
Drug Manufacturers - General 5.33%
Novo Nordisk A/S
CO:NOVO-B
Drug Manufacturers - General 0.09%
Zhejiang Int'L Group Co Ltd
SHE:000411
Drug Manufacturers - General 0.00%
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR
Drug Manufacturers - General 0.07%

BCWORLD PHARM. Co. Ltd Asset Resilience Ratio by Year (2016–2024)

BCWORLD PHARM. Co. Ltd asset resilience ratio by year from 2016 to 2024. The table below shows the annual Asset Resilience Ratio data for BCWORLD PHARM. Co. Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 4.49% ₩7.91 Billion
≈ $5.36 Million
₩176.31 Billion
≈ $119.48 Million
-1.58pp
2023-12-31 6.06% ₩11.16 Billion
≈ $7.57 Million
₩184.11 Billion
≈ $124.77 Million
+1.66pp
2022-12-31 4.40% ₩8.06 Billion
≈ $5.46 Million
₩183.05 Billion
≈ $124.05 Million
+1.89pp
2021-12-31 2.51% ₩4.50 Billion
≈ $3.05 Million
₩179.36 Billion
≈ $121.55 Million
-4.00pp
2020-12-31 6.51% ₩12.56 Billion
≈ $8.51 Million
₩192.96 Billion
≈ $130.77 Million
+4.51pp
2019-12-31 2.00% ₩3.46 Billion
≈ $2.34 Million
₩172.78 Billion
≈ $117.09 Million
-0.95pp
2018-12-31 2.95% ₩4.77 Billion
≈ $3.23 Million
₩161.74 Billion
≈ $109.61 Million
-1.46pp
2017-12-31 4.41% ₩5.22 Billion
≈ $3.54 Million
₩118.34 Billion
≈ $80.20 Million
+1.70pp
2016-12-31 2.71% ₩2.61 Billion
≈ $1.77 Million
₩96.42 Billion
≈ $65.34 Million
--
pp = percentage points

About BCWORLD PHARM. Co. Ltd

KQ:200780 Korea Drug Manufacturers - General
Market Cap
$19.40 Million
₩28.63 Billion KRW
Market Cap Rank
#25052 Global
#1831 in Korea
Share Price
₩2800.00
Change (1 day)
-0.36%
52-Week Range
₩2790.00 - ₩5870.00
All Time High
₩30700.49
About

BCWORLD PHARM. Co., Ltd. operates as a pharmaceutical company in South Korea. The company provides products in various therapeutic areas comprising musculoskeletal system, digestive system, circulatory machine, central nervous system, adrenocorticosteroids, narcotic analgesics, erectile dysfunction treatment, wellbeing injection, diuretic, antitussive expectorant, vaginitis treatment, anti-tuberc… Read more